In the end, the A-share market has ushered in a positive trend. However, investors were like frightened birds after Tuesday's A-share surge and fall. They were already afraid of good news and didn't know whether to leave or stay. Personally, as long as the trend of A shares does not go bad, I will choose to stay.First, the plan mentioned that by 2027, we will strive to land a number of representative M&A cases in key industries, form a M&A transaction scale of 300 billion yuan, and activate total assets of over 2 trillion yuan;Just when everyone was still sick, A-shares ushered in good news. Shanghai issued the "Shanghai Action Plan to Support the Merger and Reorganization of Listed Companies (2025-2027)". Is this to retain injured retail investors? Next, let's discuss it in detail.
In the end, the A-share market has ushered in a positive trend. However, investors were like frightened birds after Tuesday's A-share surge and fall. They were already afraid of good news and didn't know whether to leave or stay. Personally, as long as the trend of A shares does not go bad, I will choose to stay.Shanghai's announcement of the action plan for mergers and acquisitions of listed companies is indeed a heavy news. However, can this still retain the retail investors who were hurt by the market on Tuesday? On Tuesday, A shares opened higher and fell back, which triggered a crisis of confidence in the market to some extent. So, shall we go or stay? Let me express my personal views.The action plan can be called a heavy release in Shanghai, and I will simply classify the main contents.
Just when everyone was still sick, A-shares ushered in good news. Shanghai issued the "Shanghai Action Plan to Support the Merger and Reorganization of Listed Companies (2025-2027)". Is this to retain injured retail investors? Next, let's discuss it in detail.A shares are welcome again, and they are released heavily! Retail investors: Are you going? Is it staying?It is worth noting that the action plan ranks biomedicine in the second place, and sets up a 10 billion biomedical industry M&A fund, which is basically the same as the status of integrated circuits. In addition, the action plan puts the merger of securities companies at the end, and its status has declined.